Andrew Karaba
akaraba.bsky.social
Andrew Karaba
@akaraba.bsky.social
Transplant/Oncology Infectious Diseases Physician-Scientist. Virologist. Dad. Homebrewer. Casual birder. #IDSky
Is he a Cubs or a Sox fan?
May 8, 2025 at 5:37 PM
Great work by @sarabelga.bsky.social and colleagues!
May 8, 2025 at 2:26 PM
Great work Tori! 👏
January 18, 2025 at 12:11 AM
tl;dr version - very heterogenous response to RSV vaccines among immunocompromised patients (mostly SOT). Only ~60% "seroconverted" meaning had at least 4 fold rise. Slightly better chance of seroconverting and achieving "high titer" response among those that received adjuvanted vaccine.#IDsky #TxID
December 30, 2024 at 7:28 PM
Seems like they had a lot of lead time so hopefully plenty of time to get updated on all vaccines since I imagine won’t respond well for some time afterwards. #idsky #txid
December 18, 2024 at 12:35 AM
I never use cephalexin. Terrible dosing schedule. If not worried about MRSA usually go with cefadroxil. If c/f MRSA then usually use linezolid. #IDsky.
December 5, 2024 at 3:20 PM
The opportunity to participate in this research. Connecting me to others in the field. Advocating for me to get resources and talks.
December 4, 2024 at 12:34 AM
What kind of cocktail?
November 23, 2024 at 12:14 AM
a couple that come to mind...
BLING III
HOPE Kidney NEJM
...lots of good ones out there though I am sure I am forgetting
November 21, 2024 at 9:57 PM
November 21, 2024 at 12:55 PM
Big thanks to co-authors, especially Jiashu for analysis, Caroline and Scott for running the assays, Rob and Lorien for guidance/funding, and Chirag and Stu for the mentorship.
November 21, 2024 at 12:55 PM